What is Intellia Therapeutics's revenue?

Intellia Therapeutics (NTLA) reported revenue of $15.05M in Q1 2026.

How has Intellia Therapeutics's revenue changed year-over-year?

Intellia Therapeutics's revenue decreased by 9.5% year-over-year, from $16.63M to $15.05M.

What is the long-term trend for Intellia Therapeutics's revenue?

Over 4 years (2021 to 2025), Intellia Therapeutics's revenue has grown at a 19.6% compound annual growth rate (CAGR), from $33.05M to $67.67M.

Intellia Therapeutics NTLA Revenue

Revenue at other companies

HTF

Heartflow, Inc. Common StockHTFL

$52.59M+41.3%

Cal-Maine FoodsCALM

$666.95M-53.0%

DJT

Trump Media & Technology GroupDJT

$871.2K+6.1%

ADMA BiologicsADMA

$114.49M-0.3%

Minerals TechnologiesMTX

$546.9M+11.2%

Lincoln Educational Services CorporationLINC

$143.96M+22.5%

Other financials

Income statement

See full

Revenue$15.0M-9.5%

Operating income-$100.5M+16.8%

Net income-$96.2M+15.8%

EPS (diluted)-$0.81+26.4%

Balance sheet

See full

Cash & equivalents$134.7M+6.2%

Total debt$80.5M-32.5%

Total equity$620.9M-20.4%

Total assets$758.8M-23.1%

Cash flow

See full

Operating cash flow-$117.3M+21.2%

CapEx$79.0K-89.3%

Free cash flow-$117.4M+21.5%

Valuation

See full

Market cap$2.17B+106%

Profitability

See full

Operating margin-636.6%-202pp

Net margin-597%-194pp

FCF margin-550.2%-140pp

Returns & leverage

See full

Return on equity-56.3%-1.5pp

Debt / equity0.1×0.0×

Current ratio6.1×+1.2×

Where this comes from

Reported directly by Intellia Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Intellia Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Intellia Therapeutics's revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Intellia Therapeutics's revenue?: Intellia Therapeutics (NTLA) reported revenue of $15.05M in Q1 2026.
How has Intellia Therapeutics's revenue changed year-over-year?: Intellia Therapeutics's revenue decreased by 9.5% year-over-year, from $16.63M to $15.05M.
What is the long-term trend for Intellia Therapeutics's revenue?: Over 4 years (2021 to 2025), Intellia Therapeutics's revenue has grown at a 19.6% compound annual growth rate (CAGR), from $33.05M to $67.67M.